ERNA
Eterna Therapeutics Inc

10,915
Loading...
Loading...
News
all
press releases
Ernexa Stock Drops On 1-For-15 Reverse Stock Split To Regain Nasdaq Compliance: Retail Sentiment Improves But Stays Bearish
As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares on a split-adjusted basis.
Stocktwits·3mo ago
News Placeholder
More News
News Placeholder
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ( Eterna or the Company ), a life science company committed to realizing the potential of mRNA cell...
Globe Newswire·2y ago
News Placeholder
Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Up 11.7% in January
Eterna Therapeutics Inc. (NASDAQ:ERNA Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 147,900 shares, an increase of...
Ticker Report·2y ago
News Placeholder
Eterna Therapeutics files to sell 18.2M shares for holders
Eterna Therapeutics files to sell 18.2M shares for holders...
SeekingAlpha.com: All News·2y ago
News Placeholder
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ( Eterna or the Company ), a life science company committed to realizing the potential of mRNA cell...
Globe Newswire·2y ago

Latest ERNA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.